EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma

Benjamin A Y Cher, Christopher J Zimmermann, Juan G Favela, Linda C Stafford, Daniel Bolt, Shishir K Maithel, Mihir M Shah, Syed A Ahmad, Sameer H Patel, Robert Martin, Charles R Scoggins, Nipun Merchant und 8 weitere

HPB · 2025-11 · 27 (11) · 1410-1417

DOI: 10.1016/j.hpb.2025.07.017 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift HPB, 2025-11. Verfasst von Benjamin A Y Cher und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Wisconsin School of Medicine and Public Health, USA. Hauptthemen laut MEDLINE: Pancreatectomy, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Health Knowledge, Attitudes, Practice. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pancreatic resection offers the only chance for cure for pancreatic ductal adenocarcinoma, but resection is associated with significant morbidity. Data are lacking about whether patients understand the risks/benefits of surgical resection. This survey study prospectively assessed patient understanding of expected oncologic outcomes after pancreatectomy. METHODS: A 14-question survey was distributed between 2020 and 2022 to patients planning to undergo pancreatectomy at eight geographically diverse institutions performing high-volume pancreatic surgery. The survey assessed demographics, expectations about post-resection outcomes, and perceived quality of patient-surgeon communication. Associations between demographics and survey responses were assessed with Fisher's exact test and Goodman-Kruskal's lambda. RESULTS: 152 surveys were received (response rate 39 %; n = 152/376). Almost all patients believed surgery was likely to prolong survival (146/147, 99 %); cure their cancer (126/141, 89 %); and/or ameliorate health problems due to cancer (127/136, 93 %). Regarding patient-surgeon communication, 134/150 (89 %) reported surgeons always listened carefully, and 134/150 (89 %) reported surgeons gave clear explanations. There were no meaningful associations between demographics and understanding of expected post-resection outcomes. DISCUSSION: Most patients believed surgery was likely curative and were satisfied with patient-surgeon communication. These data outline a critical opportunity for surgical oncologists to improve pre-operative counseling and ensure patients have accurate information to support complex decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreatectomyPancreatic NeoplasmsCarcinoma, Pancreatic DuctalHealth Knowledge, Attitudes, PracticeHumansFemaleMaleMiddle AgedAgedPhysician-Patient RelationsSurveys and QuestionnairesProspective StudiesTreatment OutcomeAdult

Autor:innen und Institutionen

  • Department of Surgery, University of Wisconsin School of Medicine and Public Health, USA.
  • Department of Surgery, UCHealth Northern Colorado, Fort Collins, CO, USA.
  • Department of Educational Psychology, University of Wisconsin, Madison, USA.
  • Department of Surgery, Emory University, Winship Cancer Institute, Atlanta, GA, USA.
  • Department of Surgery, University of Cincinnati, USA.
  • Department of Surgery, University of Louisville, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Cher, B. A. Y., Zimmermann, C. J., Favela, J. G., Stafford, L. C., Bolt, D., Maithel, S. K., Shah, M. M., Ahmad, S. A., Patel, S. H., Martin, R., Scoggins, C. R., Merchant, N., Datta, J., Kim, H., LeCompte, M., Hammill, C. W., Snyder, R. A., Parikh, A. A., Weber, S. M., & Abbott, D. E. (2025). Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma. HPB, 27(11), 1410-1417. https://doi.org/10.1016/j.hpb.2025.07.017

Vancouver

Cher BAY, Zimmermann CJ, Favela JG, Stafford LC, Bolt D, Maithel SK, et al. Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma. HPB. 2025;27(11):1410-1417. doi:10.1016/j.hpb.2025.07.017

BibTeX
@article{Cher2025,
  author = {Cher, Benjamin A Y and Zimmermann, Christopher J and Favela, Juan G and Stafford, Linda C and Bolt, Daniel and Maithel, Shishir K and Shah, Mihir M and Ahmad, Syed A and Patel, Sameer H and Martin, Robert and Scoggins, Charles R and Merchant, Nipun and Datta, Jash and Kim, Hj and LeCompte, Michael and Hammill, Chet W and Snyder, Rebecca A and Parikh, Alexander A and Weber, Sharon M and Abbott, Daniel E},
  title = {Patient expectations about the oncologic benefit of pancreatectomy for pancreatic ductal adenocarcinoma},
  journal = {HPB},
  year = {2025},
  volume = {27},
  number = {11},
  pages = {1410--1417},
  doi = {10.1016/j.hpb.2025.07.017}
}
Kostenlos starten →